Anti-Inflammatory and Immunomodulatory Properties of Azithromycin Involved in Treatment and Prevention of Chronic Lung Allograft Rejection-Reference-Cited by-同舟云学术

Anti-Inflammatory and Immunomodulatory Properties of Azithromycin Involved in Treatment and Prevention of Chronic Lung Allograft Rejection

Published:2012-07-27 Issue:2 Volume:94 Page:101-109
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Vos Robin,Vanaudenaerde Bart M.,Verleden Stijn E.,Ruttens David,Vaneylen Annemie,Van Raemdonck Dirk E.,Dupont Lieven J.,Verleden Geert M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference96 articles.

1. . Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria.;Estenne;J Heart Lung Transplant,2002

2. . Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies.;Hagedorn;Immunology,2010

3. . Risk factors for bronchiolitis obliterans: A systematic review of recent publications.;Sharples;J Heart Lung Transplant,2002

4. Geudens N, et al..;Vos;Pseudomonal airway colonisation: Risk factor for bronchiolitis obliterans syndrome after lung transplantation Eur Respir J,2008

5. . The impact of traffic air pollution on chronic rejection and mortality after lung transplantation.;Nawrot;Thorax,2011

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection;American Journal of Respiratory and Critical Care Medicine;2024-06-01

2. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults;European Respiratory Journal;2024-03

3. Choice of Medications for Lung Transplantation;Organ and Tissue Transplantation;2024

4. Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction;Pharmacological Reviews;2023-06-09

5. La dysfonction chronique du greffon pulmonaire en 2022 : une entité mieux comprise et un défi thérapeutique;Revue des Maladies Respiratoires;2023-04